ABEO logo

Abeona Therapeutics (ABEO) Working Capital

Annual Working Capital

$42.31 M
-$3.00 M-6.63%

December 31, 2023

Summary

Performance

1-Year Change

-6.63%

3-Year Change

-24.14%

5-Year Change

-38.22%

15-Year Change

-68.65%

ABEO Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

47.01%
ABEO annual working capital is higher than 47.01% of companies in Healthcare sector

High & Low

All-time High

$134.99 M
ABEO annual working capital is currently -68.65% below its historical high of $134.99 million

3-Year Low

$39.67 M
ABEO annual working capital is currently +6.67% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ABEO previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 18, 2025
ABEO next annual earnings announcement is scheduled for Mar 18, 2025

OtherABEObalance sheetmetrics:

Annual Book Value

$14.83 M
ABEO annual book value is $14.83 million

Annual Retained Earnings

-$749.52 M
ABEO annual retained earnings is -$749.52 million

Annual Total Assets

$64.00 M
ABEO annual total assets is $64.00 million

Annual Total Liabilities

$49.18 M
ABEO annual total liabilities is $49.18 million

Quarterly Working Capital

$94.23 M
-$14.83 M-13.59%

September 30, 2024

Summary

Performance

3-Month Change

-13.59%

1-Year Change

+122.7%

3-Year Change

+127.44%

5-Year Change

+221.03%

ABEO Quarterly Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

57.87%
ABEO quarterly working capital is higher than 57.87% of companies in Healthcare sector

High & Low

All-time High

$134.99 M
ABEO quarterly working capital is currently -30.19% below its historical high of $134.99 million

3-Year Low

$12.90 M
ABEO quarterly working capital is currently +630.67% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ABEO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 18, 2025
ABEO next earnings announcement is scheduled for Mar 18, 2025

OtherABEObalance sheetmetrics:

Quarterly Book Value

$45.77 M
ABEO quarterly book value is $45.77 million

Quarterly Retained Earnings

-$803.97 M
ABEO quarterly retained earnings is -$803.97 million

Quarterly Total Assets

$120.59 M
ABEO quarterly total assets is $120.59 million

Quarterly Total Liabilities

$74.82 M
ABEO quarterly total liabilities is $74.82 million

Working Capital Formula

Working Capital = Current Assets − Current Liabilities

Annual Working Capital

$42.31 M
ABEO annual working capital is $42.31 million

Annual Current Assets

$55.74 M
ABEO annual total current assets is $55.74 million

Annual Current Liabilities

$13.42 M
ABEO annual total current liabilities is $13.42 million

ABEO Working Capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-6.6%+122.7%
3 y3 years-24.1%+127.4%
5 y5 years-38.2%+221.0%

ABEO Working Capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-6.6%+6.7%-13.6%+630.7%
5 y5-year-54.8%+6.7%-13.6%+630.7%
alltimeall time-68.7%+576.7%-30.2%+829.5%

Abeona Therapeutics Working Capital History

DateAnnualQuarterly
Sep 2024
-
$94.23 M(-13.6%)
Jun 2024
-
$109.06 M(+98.9%)
Mar 2024
-
$54.84 M(+29.6%)
Dec 2023
$42.31 M(-6.6%)
$42.31 M(-13.4%)
Sep 2023
-
$48.85 M(+41.2%)
Jun 2023
-
$34.60 M(-2.3%)
Mar 2023
-
$35.42 M(-21.8%)
Dec 2022
$45.32 M(+14.2%)
$45.32 M(+251.4%)
Sep 2022
-
$12.90 M(-22.4%)
Jun 2022
-
$16.61 M(-38.2%)
Mar 2022
-
$26.87 M(-32.3%)
Dec 2021
$39.67 M(-28.9%)
$39.67 M(-4.3%)
Sep 2021
-
$41.43 M(+11.9%)
Jun 2021
-
$37.01 M(-22.5%)
Mar 2021
-
$47.76 M(-14.4%)
Dec 2020
$55.78 M(-40.5%)
$55.78 M(-15.3%)
Sep 2020
-
$65.82 M(-7.6%)
Jun 2020
-
$71.25 M(-13.3%)
Mar 2020
-
$82.14 M(-12.3%)
Dec 2019
$93.69 M(+36.8%)
$93.69 M(+219.2%)
Sep 2019
-
$29.35 M(-25.4%)
Jun 2019
-
$39.35 M(-21.8%)
Mar 2019
-
$50.30 M(-26.6%)
Dec 2018
$68.50 M(-49.3%)
$68.50 M(-34.3%)
Sep 2018
-
$104.22 M(-10.2%)
Jun 2018
-
$116.04 M(-9.1%)
Mar 2018
-
$127.70 M(-5.4%)
Dec 2017
$134.99 M(+120.8%)
$134.99 M(+142.1%)
Sep 2017
-
$55.76 M(+1.3%)
Jun 2017
-
$55.05 M(-4.7%)
Mar 2017
-
$57.76 M(-5.5%)
Dec 2016
$61.13 M(+56.4%)
$61.13 M(+140.3%)
Sep 2016
-
$25.43 M(-1.9%)
Jun 2016
-
$25.91 M(-14.2%)
Mar 2016
-
$30.20 M(-22.8%)
Dec 2015
$39.09 M(+351.6%)
$39.09 M(-7.2%)
Sep 2015
-
$42.12 M(+45.0%)
Jun 2015
-
$29.04 M(+317.9%)
Mar 2015
-
$6.95 M(-19.7%)
Dec 2014
$8.66 M(-203.2%)
$8.66 M(-170.0%)
Sep 2014
-
-$12.37 M(+12.8%)
Jun 2014
-
-$10.97 M(+14.2%)
Mar 2014
-
-$9.60 M(+14.5%)
Dec 2013
-$8.39 M(+69.5%)
-$8.39 M(+20.4%)
Sep 2013
-
-$6.97 M(+28.5%)
Jun 2013
-
-$5.42 M(-10.7%)
Mar 2013
-
-$6.07 M(+22.7%)
Dec 2012
-$4.95 M(-44.3%)
-$4.95 M(-39.2%)
Sep 2012
-
-$8.13 M(-32.3%)
Jun 2012
-
-$12.02 M(+18.5%)
Mar 2012
-
-$10.14 M(+14.2%)
Dec 2011
-$8.88 M
-$8.88 M(-29.4%)
Sep 2011
-
-$12.58 M(+49.8%)
DateAnnualQuarterly
Jun 2011
-
-$8.40 M(-1.2%)
Mar 2011
-
-$8.50 M(+38.5%)
Dec 2010
-$6.14 M(-22.8%)
-$6.14 M(-52.5%)
Sep 2010
-
-$12.92 M(+147.0%)
Jun 2010
-
-$5.23 M(+24.9%)
Mar 2010
-
-$4.19 M(-47.3%)
Dec 2009
-$7.95 M(+72.3%)
-$7.95 M(+27.1%)
Sep 2009
-
-$6.25 M(+7.0%)
Jun 2009
-
-$5.84 M(+45.5%)
Mar 2009
-
-$4.01 M(-13.0%)
Dec 2008
-$4.61 M(-173.9%)
-$4.61 M(-5939.2%)
Sep 2008
-
$79.00 K(-96.9%)
Jun 2008
-
$2.57 M(-37.9%)
Mar 2008
-
$4.14 M(-33.7%)
Dec 2007
$6.24 M(-207.9%)
$6.24 M(-149.4%)
Sep 2007
-
-$12.62 M(+14.7%)
Jun 2007
-
-$11.01 M(+18.4%)
Mar 2007
-
-$9.30 M(+60.9%)
Dec 2006
-$5.78 M(-529.9%)
-$5.78 M(-43.9%)
Sep 2006
-
-$10.30 M(+18.8%)
Jun 2006
-
-$8.67 M(+168.5%)
Mar 2006
-
-$3.23 M(-340.1%)
Dec 2005
$1.34 M(-118.2%)
$1.34 M(-114.2%)
Sep 2005
-
-$9.47 M(-26.6%)
Jun 2005
-
-$12.91 M(+36.3%)
Mar 2005
-
-$9.47 M(+28.1%)
Dec 2004
-$7.39 M(-713.0%)
-$7.39 M(+48.3%)
Sep 2004
-
-$4.99 M(-186.7%)
Jun 2004
-
$5.75 M(-28.3%)
Mar 2004
-
$8.02 M(+565.2%)
Dec 2003
$1.21 M(-84.1%)
$1.21 M(-64.6%)
Sep 2003
-
$3.41 M(-40.0%)
Jun 2003
-
$5.68 M(+10.3%)
Mar 2003
-
$5.15 M(-32.2%)
Dec 2002
$7.59 M(-59.0%)
$7.59 M(-21.4%)
Sep 2002
-
$9.66 M(-29.5%)
Jun 2002
-
$13.70 M(-14.5%)
Mar 2002
-
$16.01 M(-13.5%)
Dec 2001
$18.52 M(-24.1%)
$18.52 M(-10.3%)
Sep 2001
-
$20.66 M(-6.2%)
Jun 2001
-
$22.02 M(-6.0%)
Mar 2001
-
$23.42 M(-4.0%)
Dec 2000
$24.40 M(>+9900.0%)
$24.40 M(-5.1%)
Sep 2000
-
$25.72 M(+109.9%)
Jun 2000
-
$12.25 M(+19.3%)
Mar 2000
-
$10.27 M(>+9900.0%)
Dec 1999
$100.00 K(-90.0%)
$100.00 K(-91.2%)
Sep 1999
-
$1.13 M(-464.5%)
Jun 1999
-
-$310.00 K(-207.6%)
Mar 1999
-
$288.00 K
Dec 1998
$1.00 M(-563.0%)
-
Dec 1997
-$216.00 K(-105.5%)
-
Dec 1996
$3.94 M(+133.0%)
-
Dec 1995
$1.69 M
-

FAQ

  • What is Abeona Therapeutics annual working capital?
  • What is the all time high annual working capital for Abeona Therapeutics?
  • What is Abeona Therapeutics annual working capital year-on-year change?
  • What is Abeona Therapeutics quarterly working capital?
  • What is the all time high quarterly working capital for Abeona Therapeutics?
  • What is Abeona Therapeutics quarterly working capital year-on-year change?

What is Abeona Therapeutics annual working capital?

The current annual working capital of ABEO is $42.31 M

What is the all time high annual working capital for Abeona Therapeutics?

Abeona Therapeutics all-time high annual working capital is $134.99 M

What is Abeona Therapeutics annual working capital year-on-year change?

Over the past year, ABEO annual working capital has changed by -$3.00 M (-6.63%)

What is Abeona Therapeutics quarterly working capital?

The current quarterly working capital of ABEO is $94.23 M

What is the all time high quarterly working capital for Abeona Therapeutics?

Abeona Therapeutics all-time high quarterly working capital is $134.99 M

What is Abeona Therapeutics quarterly working capital year-on-year change?

Over the past year, ABEO quarterly working capital has changed by +$51.92 M (+122.70%)